Interactions between plasma levels of 25-hydroxyvitamin d, insulin-like growth factor (igf)-1 and c-peptide with risk of colorectal cancer

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Wu, Kana ^a   Feskanich, Diane ^b   Fuchs, Charles S ^b,d   Chan, Andrew T ^b,c   Willett, Walter C ^a,b   Hollis, Bruce W ^e   Pollak, Michael N ^f   Giovannucci, Edward ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C PEPTIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; RISK ASSESSMENT; RISK REDUCTION; VITAMIN BLOOD LEVEL; ADULT; AGED; BLOOD; COLORECTAL TUMOR; METABOLISM; MIDDLE AGED; QUESTIONNAIRE; RISK FACTOR;

ADULT; AGED; C-PEPTIDE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; VITAMIN D;

EID: 84855175450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028520     Document Type: Article

References (76)

1. Garland CF, Garland FC, (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9: 227-231.
2. Garland CF, Garland FC, (2005) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol.
3. Sandhu MS, Dunger DB, Giovannucci EL, (2002) Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. Journal of the National Cancer Institute 94: 972-980.
4. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW, (1995) Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol 142: 608-611.
5. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, et al. (1997) Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8: 615-625.
6. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, et al. (2004) Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13: 1502-1508.
7. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, et al. (1989) Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2: 1176-1178.
8. Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, et al. (2007) A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. Journal of the National Cancer Institute 99: 1120-1129.
9. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S, (2007) Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. British journal of cancer 97: 446-451.
10. Woolcott CG, Wilkens LR, Nomura AM, Horst RL, Goodman MT, et al. (2010) Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 19: 130-134.
11. Rajaram S, Baylink DJ, Mohan S, (1997) Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18: 801-831.
12. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, et al. (2008) Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer research 68: 329-337.
13. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, et al. (2000) Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. Journal of the National Cancer Institute 92: 1592-1600.
14. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, et al. (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. Journal of the National Cancer Institute 91: 620-625.
15. Max JB, Limburg PJ, Ogunseitan A, Stolzenberg-Solomon RZ, Vierkant RA, et al. (2008) IGF-I, IGFBP-3, and IGF-I/IGFBP-3 ratio: no association with incident colorectal cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev 17: 1832-1834.
16. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S, (2007) Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. International journal of cancer 120: 2007-2012.
17. Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, et al. (2002) Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 50: 642-646.
18. Probst-Hensch NM, Yuan JM, Stanczyk FZ, Gao YT, Ross RK, et al. (2001) IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. British journal of cancer 85: 1695-1699.
19. Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, et al. (2009) Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. International journal of cancer.
20. Bonser AM, Garcia-Webb P, (1984) C-peptide measurement: methods and clinical utility. Critical reviews in clinical laboratory sciences 19: 297-352.
21. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, et al. (2005) A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 14: 850-855.
22. Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, et al. (2004) A prospective study of plasma C-peptide and colorectal cancer risk in men. Journal of the National Cancer Institute 96: 546-553.
23. Jenab M, Riboli E, Cleveland RJ, Norat T, Rinaldi S, et al. (2007) Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. International journal of cancer 121: 368-376.
24. Clemmons DR, (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine & growth factor reviews 8: 45-62.
25. Thissen JP, Ketelslegers JM, Underwood LE, (1994) Nutritional regulation of the insulin-like growth factors. Endocr Rev 15: 80-101.
26. Komninou D, Ayonote A, Richie JP Jr, Rigas B, (2003) Insulin resistance and its contribution to colon carcinogenesis. Experimental biology and medicine (Maywood, N.J 228: 396-405.
27. Allen NE, Appleby PN, Kaaks R, Rinaldi S, Davey GK, et al. (2003) Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14: 65-74.
28. DeLellis K, Rinaldi S, Kaaks RJ, Kolonel LN, Henderson B, et al. (2004) Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 13: 1444-1451.
29. Gapstur SM, Kopp P, Chiu BC, Gann PH, Colangelo LA, et al. (2004) Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study. Cancer Epidemiol Biomarkers Prev 13: 2208-2216.
30. Holmes MD, Pollak MN, Hankinson SE, (2002) Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11: 862-867.
31. Lukanova A, Toniolo P, Akhmedkhanov A, Hunt K, Rinaldi S, et al. (2001) A cross-sectional study of IGF-I determinants in women. Eur J Cancer Prev 10: 443-452.
32. Chang S, Wu X, Yu H, Spitz MR, (2002) Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. Cancer Epidemiol Biomarkers Prev 11: 758-766.
33. Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, et al. (2009) The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 18: 1333-1340.
34. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, et al. (2004) Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. European journal of endocrinology/ European Federation of Endocrine Societies 150: 161-171.
35. Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Rinaldi S, et al. (2001) Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1-3 in premenopausal women: physical activity and anthropometry (Netherlands). Cancer Causes Control 12: 951-958.
36. Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, et al. (2004) Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1,-2 and-3 in women in the Netherlands. Cancer Causes Control 15: 787-796.
37. Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, et al. (2003) Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 12: 84-89.
38. Holmes MD, Pollak MN, Willett WC, Hankinson SE, (2002) Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11: 852-861.
39. Boyle BJ, Zhao XY, Cohen P, Feldman D, (2001) Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. The Journal of urology 165: 1319-1324.
40. Peng L, Malloy PJ, Feldman D, (2004) Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Molecular endocrinology (Baltimore, Md 18: 1109-1119.
41. Matilainen M, Malinen M, Saavalainen K, Carlberg C, (2005) Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res 33: 5521-5532.
42. Ma J, Giovannucci E, Pollak M, Chan JM, Gaziano JM, et al. (2001) Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. Journal of the National Cancer Institute 93: 1330-1336.
43. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, et al. (1995) Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. The Journal of clinical endocrinology and metabolism 80: 2534-2542.
44. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, et al. (1991) Prospective study of alcohol consumption and risk of coronary disease in men [see comments]. Lancet 338: 464-468.
45. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, et al. (1994) Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer research 54: 2390-2397.
46. Colditz GA, (1995) The nurses' health study: a cohort of US women followed since 1976. J Am Med Womens Assoc 50: 40-44.
47. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS, (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. Journal of the National Cancer Institute 97: 1688-1694.
48. Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, et al. (1995) Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. Journal of the National Cancer Institute 87: 1297-1302.
49. Hollis BW, (1997) Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol 282: 174-186.
50. Willett WC, (1998) Issues in analysis and presentation of dietary data. In: Willett WC, editors. Nutritional epidemiology New York Oxford University Press pp. 321-345.
51. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, et al. (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1: 466-473.
52. Chasan-Taber S, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, et al. (1996) Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology 7: 81-86.
53. Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, et al. (1993) Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. Journal of the American Dietetic Association 93: 790-796.
54. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, et al. (1992) Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. American journal of epidemiology 135: 1114-1126; discussion 1127-1136.
55. Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, Browne ML, (1987) Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. Journal of the American Dietetic Association 87: 43-47.
56. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, et al. (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. American journal of epidemiology 122: 51-65.
57. Karlson EW, Chang SC, Cui J, Chibnik LB, Fraser PA, et al. (2009) Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Annals of the rheumatic diseases 69: 54-60.
58. Rothman KJ, (2002) Epidemiology. New York, NY An Introduction. Oxford University Press.
59. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A, (2005) Calculating measures of biological interaction. European journal of epidemiology 20: 575-579.
60. Lundberg M, Fredlund P, Hallqvist J, Diderichsen F, (1996) A SAS program calculating three measures of interaction with confidence intervals. Epidemiology 7: 655-656.
61. Hosmer DW, Lemeshow S, (1992) Confidence interval estimation of interaction. Epidemiology 3: 452-456.
62. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, et al. (2006) C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 15: 750-755.
63. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R, (2009) Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30: 586-623.
64. Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, et al. (2008) The role of insulin receptors and IGF-I receptors in cancer and other diseases. Archives of physiology and biochemistry 114: 23-37.
65. Giovannucci E, (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131: 3109S-3120S.
66. Giovannucci E, (2006) The epidemiology of vitamin D and colorectal cancer: recent findings. Curr Opin Gastroenterol 22: 24-29.
67. Lamprecht SA, Lipkin M, (2001) Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci 952: 73-87.
68. Pisani P, (2008) Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Archives of physiology and biochemistry 114: 63-70.
69. Cotton S, Sharp L, Little J, (1996) The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Critical Reviews in Oncogenesis 7: 293-342.
70. Fearon ER, Vogelstein B, (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
71. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S Gender difference in the association of insulin, the insulin-like growth factor axis with colorectal neoplasiaInternationaljournalofobesity, (2005).
72. Wu T, Willett WC, Giovannucci E, (2009) Plasma C-peptide is inversely associated with calcium intake in women and with plasma 25-hydroxy vitamin D in men. The Journal of nutrition 139: 547-554.
73. Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL, (2002) Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 94: 437-446.
74. Norman AW, Vitamin D, (1990) Present knowledge in nutrition. In: Brown ML, editors. International Life Sciences Institute, Nutrition Foundation Washington, D.C. pp. 212-223.
75. Platz EA, Pollak MN, Rimm EB, Majeed N, Tao Y, et al. (1999) Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev 8: 1107-1110.
76. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E, (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15: 255-265.